Clinical trial

A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM8969

NCT07581431

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-06-15

PhasePHASE1

Study timeline

Study start (actual)2026-06-15Date precision: day

Registry last updated2026-06-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy Subjects (HS)unresolved

Obese Adult Participants at Risk of Cardiovascular Diseaseunresolved

Interventions

ISM8969 tablets or placeboDRUG

Sponsors & collaborators

InSilico Medicine Hong Kong Limitedlead sponsor

Mapped research locations

MelbourneVictoria, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07581431 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.